Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
14M
-
Shares change
-
+397K
-
Total reported value, excl. options
-
$374M
-
Value change
-
+$10.5M
-
Number of buys
-
24
-
Number of sells
-
-5
-
Price
-
$26.72
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q4 2021
36 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q4 2021.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14M shares
of 64.3M outstanding shares and own 21.81% of the company stock.
Largest 10 shareholders include FMR LLC (3.15M shares), Abingworth LLP (2.96M shares), Sofinnova Investments, Inc. (2.91M shares), CITADEL ADVISORS LLC (1.73M shares), Alphabet Inc. (714K shares), Octagon Capital Advisors LP (671K shares), BlackRock Inc. (455K shares), VANGUARD GROUP INC (389K shares), Kynam Capital Management, LP (253K shares), and STATE STREET CORP (123K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.